Sensei Biotherapeutics (SNSE) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for Sensei Biotherapeutics (SNSE).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||
Total Revenue | 390K (+62.50%) | 240K (-17.24%) | 290K (-9.38%) | 320K (-17.95%) | 390K (-25.00%) | 520K (-11.86%) | 590K (-11.94%) | 670K (-12.99%) | 770K (-7.23%) | 830K (-5.68%) | 880K (-7.37%) | 950K (-2.06%) | 970K (+59.02%) | 610K (+17.31%) | 520K (+48.57%) | 350K (+12.90%) | 310K (-6.06%) | 330K (+17.86%) | 280K (+47.37%) | 190K | - | - | - | - | - |
Operating Expenses | |||||||||||||||||||||||||
Research And Development | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -3.36M | - | - | 3.37M | -2.19M | - | - | 2.19M |
Selling General And Administrative | 20M (+606.45%) | 2.79M (+20.26%) | 2.32M (-13.11%) | 2.67M (-24.79%) | 3.55M (+25.44%) | 2.83M (-11.29%) | 3.19M (-0.31%) | 3.20M (-16.01%) | 3.81M (+4.38%) | 3.65M (-6.89%) | 3.92M (-27.27%) | 5.39M (-7.07%) | 5.80M (+1.75%) | 5.70M (+20.00%) | 4.75M (+9.95%) | 4.32M (-14.12%) | 5.03M (+45.38%) | 3.46M (-10.59%) | 3.87M (-0.51%) | 3.89M (-15.43%) | 4.60M (+82.54%) | 2.52M (+40.78%) | 1.79M (+36.64%) | 1.31M (-31.41%) | 1.91M |
Operating Expenses | 171M (+3340.12%) | 4.96M (+2.27%) | 4.85M (-6.91%) | 5.21M (-28.34%) | 7.27M (-12.09%) | 8.27M (+5.75%) | 7.82M (+0.39%) | 7.79M (-10.77%) | 8.73M (+7.25%) | 8.14M (+5.17%) | 7.74M (-23.97%) | 10M (-7.54%) | 11M (-15.63%) | 13M (-6.38%) | 14M (+30.16%) | 11M (-14.25%) | 12M (+32.73%) | 9.41M (-8.82%) | 10M (+5.52%) | 9.78M (+22.71%) | 7.97M (+56.89%) | 5.08M (-5.22%) | 5.36M (+9.16%) | 4.91M (+19.76%) | 4.10M |
Depreciation And Amortization | 30K (-66.67%) | 90K | - | - | 30K (-78.57%) | 140K (0.00%) | 140K (0.00%) | 140K (0.00%) | 140K (0.00%) | 140K (0.00%) | 140K (0.00%) | 140K (-12.50%) | 160K (0.00%) | 160K (+6.67%) | 150K (+7.14%) | 140K (-12.50%) | 160K (-51.52%) | 330K (+135.71%) | 140K (+16.67%) | 120K (+20.00%) | 100K (+42.86%) | 70K (+16.67%) | 60K (+20.00%) | 50K (+150.00%) | 20K |
Operating Income | |||||||||||||||||||||||||
Operating Income | -170.63M (+3340.12%) | -4.96M (+2.27%) | -4.85M (-6.91%) | -5.21M (-28.34%) | -7.27M (-12.09%) | -8.27M (+5.75%) | -7.82M (+0.39%) | -7.79M (-10.77%) | -8.73M (+7.25%) | -8.14M (+5.17%) | -7.74M (-23.97%) | -10.18M (-7.54%) | -11.01M (-15.63%) | -13.05M (-6.38%) | -13.94M (+30.16%) | -10.71M (-14.25%) | -12.49M (+32.73%) | -9.41M (-8.82%) | -10.32M (+5.52%) | -9.78M (+22.71%) | -7.97M (+56.89%) | -5.08M (-5.22%) | -5.36M (+9.16%) | -4.91M (+19.76%) | -4.10M |
Ebit | -170.63M (+3340.12%) | -4.96M (+2.27%) | -4.85M (-6.91%) | -5.21M (-28.34%) | -7.27M (-12.09%) | -8.27M (+5.75%) | -7.82M (+0.39%) | -7.79M (-10.77%) | -8.73M (+7.25%) | -8.14M (+5.17%) | -7.74M (-23.97%) | -10.18M (-7.54%) | -11.01M (-15.63%) | -13.05M (-6.38%) | -13.94M (+30.16%) | -10.71M (-14.25%) | -12.49M (+32.73%) | -9.41M (-8.82%) | -10.32M (+5.52%) | -9.78M (+22.71%) | -7.97M (+56.89%) | -5.08M (-5.22%) | -5.36M (+9.16%) | -4.91M (+19.76%) | -4.10M |
EBITDA | -170.60M (+3041.80%) | -5.43M (+19.08%) | -4.56M (-7.51%) | -4.93M (-31.91%) | -7.24M (-10.95%) | -8.13M (+5.86%) | -7.68M (+0.39%) | -7.65M (-10.94%) | -8.59M (+7.24%) | -8.01M (+5.39%) | -7.60M (-24.30%) | -10.04M (-7.47%) | -10.85M (-15.83%) | -12.89M (-6.53%) | -13.79M (+30.46%) | -10.57M (-14.27%) | -12.33M (+35.79%) | -9.08M (-10.81%) | -10.18M (+5.38%) | -9.66M (+22.74%) | -7.87M (+57.09%) | -5.01M (-5.47%) | -5.30M (+9.05%) | -4.86M (+19.12%) | -4.08M |
Other Income / Expenses | |||||||||||||||||||||||||
Interest Expense | - | - | 10K (0.00%) | 10K (0.00%) | 10K (-50.00%) | 20K (0.00%) | 20K (0.00%) | 20K (-33.33%) | 30K (0.00%) | 30K (0.00%) | 30K (-25.00%) | 40K (0.00%) | 40K | -210.00K | 10K (-94.12%) | 170K (-29.17%) | 240K (-22.58%) | 310K (+47.62%) | 210K (+40.00%) | 150K | - | 50K | - | - | 1.63M |
Net Interest Income | - | - | -10.00K (0.00%) | -10.00K (0.00%) | -10.00K (-50.00%) | -20.00K (0.00%) | -20.00K (0.00%) | -20.00K (-33.33%) | -30.00K (0.00%) | -30.00K (0.00%) | -30.00K (-25.00%) | -40.00K (0.00%) | -40.00K | 210K | -10.00K (-94.12%) | -170.00K (-29.17%) | -240.00K (-22.58%) | -310.00K (+47.62%) | -210.00K (+40.00%) | -150.00K | - | -50.00K | - | - | -1.63M |
Other Non Operating Income | - | - | - | - | 20K | - | - | - | - | -210.00K (-4.55%) | -220.00K | 70K (+600.00%) | 10K (-75.00%) | 40K (+100.00%) | 20K | - | 20K | -10.00K | - | - | - | - | - | - | - |
Net Income | |||||||||||||||||||||||||
Income Before Tax | - | -21.08M | - | - | - | -30.16M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -170.24M (+3506.78%) | -4.72M (+3.28%) | -4.57M (-7.49%) | -4.94M (-27.99%) | -6.86M (-11.71%) | -7.77M (+7.17%) | -7.25M (+1.54%) | -7.14M (-10.64%) | -7.99M (+7.83%) | -7.41M (+4.07%) | -7.12M (-24.17%) | -9.39M (-7.76%) | -10.18M (-16.76%) | -12.23M (-8.87%) | -13.42M (+27.45%) | -10.53M (-15.08%) | -12.40M (+32.34%) | -9.37M (-3.20%) | -9.68M (-0.92%) | -9.77M (+22.58%) | -7.97M (+55.36%) | -5.13M (-4.47%) | -5.37M (+9.37%) | -4.91M (+4.69%) | -4.69M |
Net Income | -170.24M (+3506.78%) | -4.72M (+3.28%) | -4.57M (-7.49%) | -4.94M (-27.99%) | -6.86M (-11.71%) | -7.77M (+7.17%) | -7.25M (+1.54%) | -7.14M (-10.64%) | -7.99M (+7.83%) | -7.41M (+4.07%) | -7.12M (-24.17%) | -9.39M (-7.76%) | -10.18M (-16.76%) | -12.23M (-8.87%) | -13.42M (+27.45%) | -10.53M (-15.08%) | -12.40M (+32.34%) | -9.37M (-3.20%) | -9.68M (-0.92%) | -9.77M (+22.58%) | -7.97M (+55.36%) | -5.13M (-4.47%) | -5.37M (+9.37%) | -4.91M (+4.69%) | -4.69M |
Comprehensive Income Net Of Tax | -170.26M (+708.07%) | -21.07M (+362.06%) | -4.56M (-7.69%) | -4.94M (-27.99%) | -6.86M (-77.10%) | -29.96M (+319.02%) | -7.15M (+0.70%) | -7.10M (-10.35%) | -7.92M (-76.22%) | -33.31M (+377.22%) | -6.98M (-23.38%) | -9.11M (-8.90%) | -10.00M (-79.70%) | -49.26M (+267.34%) | -13.41M (+23.59%) | -10.85M (-16.35%) | -12.97M (-65.07%) | -37.13M (+284.77%) | -9.65M (-2.23%) | -9.87M (+23.84%) | -7.97M (-60.54%) | -20.20M (+276.16%) | -5.37M (+9.37%) | -4.91M | - |